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for an episode of care has been introduced as an alternative payment model to control the cost of total joint arthroplasty in Medicare patients [2] [3] [4] . Given the cost burden of readmissions, all providers including hospitals who enter the bundled care initiatives must understand the cost implications of readmissions after total joint arthroplasty. CMS chose thirty-day readmission rates after elective total joint arthroplasty as an initial measure of hospital quality. To be financially sustainable in a bundled payment or never event environment, reducing the rate of readmission after total joint arthroplasty is of paramount importance to fulfill the aims of a value-driven health-care delivery system.
Reported thirty-day readmission rates after total joint arthroplasty range from 1% to 8.5% [5] [6] [7] . The most common causes of readmission include surgery-related complications such as surgical site infection and medical complications. Predictive risk factors for readmission, studied in isolation, include black race, discharge to inpatient rehabilitation, increased duration of hospital stay, advanced age, respiratory conditions, increased body mass index (BMI) 8, 9 , diabetes 10,11 , ASA (American Society of Anesthesiologists) grade >2, increased operative time 6, 12, 13 , cardiovascular problems 12 , venous thromboembolic disease 14 , smoking status 15, 16 , behavioral or neurocognitive problems, drug and alcohol abuse, physical deconditioning, and fall risk. Factors such as age, race, and ASA grade are not modifiable. The modifiable risk factors play a substantial role in the outcomes after total joint arthroplasty.
Simply assessing the predictive value of these modifiable risk factors without a tool to assess cumulative risk may not properly provide risk stratification of patients with regard to potential readmissions. Instead, an innovative model designed to better align the clinical needs and financial incentives of the patient, hospital, surgeon, and payer, when determining the need for and risk of total joint arthroplasty is important. We introduced a Perioperative Orthopaedic Surgical Home (POSH) model, which includes a Readmission Risk Assessment Tool (RRAT) that allows for risk stratification in patients undergoing elective primary total joint arthroplasty at our institution. Through this model, patients would be evaluated preoperatively for modifiable risk factors and, if the risk is deemed excessively high, surgery would be delayed until those risk factors are minimized. To allow for identification and risk stratification, the RRAT ( Fig. 1 ) was developed to provide a summation of patient comorbidities prior to undergoing primary total joint arthroplasty.
The aim of this retrospective analysis was to evaluate the relationship between the RRAT score and readmission after hip or knee arthroplasty at our institution. Readmission Risk Assessment Tool with proposed interventions.
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Materials and Methods
Data Source and Sample Selection (2) other arthroplasty-related complications, and (3) medical complications. Comorbid health conditions recorded at the index surgery were abstracted from the patients' medical records by research fellows. Modifiable risk factors that form the basis for the RRATscore were analyzed (Fig. 1) . Independent non-modifiable factors such as age, sex, and ASA grade were also analyzed as covariates.
RRATscores were calculated for the 207 readmitted patients and for two cohorts of 234 non-readmitted patients (controls). A nested case-control design of readmitted and non-readmitted patients was chosen, as it yields the best power when sample size is fixed. Since this was a pilot study, we pursued an efficient study design. Instead of calculating the score for all of the 9723 non-readmitted patients, we chose both a random and an age-matched control cohort. For the random controls, we simply selected the first 234 non-readmitted patients from a random year within the study period. Although a first-come basis is not an ideal random sampling scheme in general, in this analysis we defined the "random selection" as selection on the basis of the time of admission because we believe that the admission dates are unlikely to be associated with RRAT scores or readmissions. However, given that age is a known risk factor for readmissions 17 and for most clinical conditions within the RRAT, we further evaluated the RRAT using the age-matched design. To minimize the complexity of the analysis, we matched on the basis of the distribution of age groups rather than using one-to-one individual matching. We first divided the age groups into six intervals and then sampled controls to have the same proportion of each age interval among the cohorts. Because of the difference in age composition between the readmitted patients (cases) and nonreadmitted patients (controls), the chance of being sampled varied across age intervals.
Description of the Readmission Risk Assessment Tool (RRAT)
Based on previous studies and clinical experience, modifiable risk factors associated with readmission (Staphylococcus aureus colonization, BMI, active tobacco use, history of cardiovascular disease, history of venous thromboembolic disease 14 , neurocognitive or behavioral problems, drug or alcohol abuse problems, physical deconditioning and fall risk, and history of diabetes) 6, 18 were used in the generation of the RRAT (Fig. 1) . The tool's scoring for each risk factor was assigned on the basis of the potential severity of its association with readmissions on a scale of 1 to 3 (i.e., the higher the impact, the higher the score assigned). A BMI of >40 kg/m 2 , fasting glucose of >180 mg/dL, and nasal colonization with S. aureus were each scored 3, given their strong association with readmission. Other comorbidities were scored 1 or 2 on the basis of their severity. The total RRATscore for each individual is the cumulative sum of all scores for applicable modifiable factors. Nonmodifiable risk factors such as age, sex, race, and socioeconomic status were not included in the scoring system because they cannot be altered or optimized.
Statistical Analysis
The association between modifiable risk factors (that is, items within the RRAT) and readmission was assessed with a logistic regression model (using a generic function, generalized linear model, in the R programming language). Nonmodifiable factors such as age, sex, and ASA grade were adjusted as covariates by fitting a multiple regression model. For the age-matched control cohort, we used conditional logistic regression (clogistic function available through the R package Epi) 19 to adjust the fixed effects from different age strata. To identify whether age was a confounder or an effect modifier, we evaluated the odds of the RRAT score at each age stratum with a Cochran-Mantel-Haenszel test. Lastly, to identify patients at a relatively high risk for readmission, we calculated the odds at each RRATscore level under two assumptions: (1) a linear (increasing) relationship, and (2) the nonlinear relationship modeled by factorization of the RRAT scores. We then determined at which level a significantly higher odds of readmission was observed. Statistical significance was set at p £ 0.05. Results are presented as the median with the interquartile range and as the odds ratio (OR) with the corresponding 95% confidence interval (CI). Statistical analysis was performed, reviewed, and interpreted by experienced professionals trained in these techniques (L.J. and I.A.I.) using R statistical software 20 .
Source of Funding
No external funds were used for this study.
Results
A total of 207 (2.08%) of the 9930 patients were readmitted during the study period. Surgical site infection was the leading cause of readmission (ninety-three cases, 45%), followed by medical complications (sixty-seven cases, 32%) and other arthroplasty-related complications (forty-seven cases, 23%). Age distributions of the readmitted cases and random controls are shown in Figure 2 .
Significance of the RRAT Score
The difference in RRAT score distributions is shown in Figure 3 . In both control cohorts, most of the RRAT scores were clustered *Odds indicate the ratio of readmission to no readmission estimated by exp(b 0 1 b RRAT RRAT). The OR (odds ratio) is calculated as the odds of the current score divided by the odds of the previous score. In a linear model, the OR is assumed to be constant across score levels; therefore, odds for scores of ‡6 were available in the model estimation. However, because of the small sample size, the ratio between readmitted and control patients was unstable between scores of 4 and 6.
at 0 and 1 (63% [148] for age-matched controls and 67% [156] for random controls) compared with only 29% (fifty-nine) for the readmitted cases. Patients with a score of ‡5 constituted 15% of the readmitted patients compared with <1% (two) of the nonreadmitted patients in the random controls and 2% (five) of the age-matched controls. There was no patient in either control group with a score of ‡7. The median RRAT scores were 3 (IQR [interquartile range], 1 to 4) and 1 (IQR, 0 to 2) for the readmitted and non-readmitted groups, respectively. Because the RRAT score distribution among readmitted patients was skewed to the right, the effect of the RRAT score on readmission was significant in all models, regardless of the choice of controls and analysis methods.
When analyzed for age effects (model set 4 in Table I ), the patients forty years of age and younger showed a nonsignificant RRAT scoring effect but all other age groups showed a significant and consistent OR ranging between 1.5 and 1.9 per RRAT unit (p < 0.001 by the Cochran-Mantel-Haenszel test). The interaction between age and RRAT score was not significant (OR = 1.02, 95% CI = 0.77 to 1.37, p = 0.878).
RRAT Item Evaluation
The three items that were significantly associated with readmission regardless of age adjustment were diabetes (OR = 2.96, 95% CI = 1.52 to 5.77, p < 0.001), history of venous thromboembolic disease (OR = 8.13, 95% CI = 4.89 to 13.52, p < 0.01), Empirical age distribution of readmitted cases and random controls.
and smoking (OR = 1.66, 95% CI = 1.00 to 2.77, p = 0.05). However, a history of cardiovascular disease, obesity, and other neurocognitive issues were not significant (Table II) . Although these numbers were derived from the random control cohort, the estimates from the age-matched cohort were not statistically different.
Identifying a Higher-Risk Group Using RRAT Scores
Higher RRAT scores were correlated with a higher chance of readmission. Patients with an RRAT score of ‡3 had odds of >1 regardless of the model assumptions, and this was consistent with the raw data showing elevated readmission risk (at a score of 3, the odds were 2.33 from the raw data and 1.66 from the linear model with age adjustment). We also observed that an RRAT score of ‡5 yielded significantly greater odds of readmission (Table III) .
Discussion
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arly readmission within thirty days after surgery is increasingly being examined as a quality metric 21 . The proposed Readmission Risk Assessment Tool score distribution of readmitted cases (red), random controls (white), and age-matched controls (gray).
changes in the hospital and surgeon compensation models in the United States are driven by pay-for-performance measures. Any unplanned readmission will have negative financial consequences on the provider and health-care institution. Voluminous research has been conducted to characterize readmissions and predict the factors associated with readmissions. The results are conflicting and provide a variety of clinical guidelines 7, [22] [23] [24] [25] . Some studies emphasize readmission risk factors that are not modifiable 6, 12 . Recently, there have been reports focusing on modifiable risk factors that are associated with readmissions. Among the major independent risk factors identified, active tobacco use, S. aureus colonization, high BMI, as well as diabetes mellitus and related complications of that disease are all potentially modifiable 11, 18, [26] [27] [28] [29] [30] [31] [32] . However, it may not be possible to completely modify an individual risk factor to an acceptable range 32 . Additionally, acceptable risk may be defined differently by different stakeholders. By quantifying risk as a function of the chance of readmission, acceptable risk becomes easier to define.
Suboptimal outcomes after total joint arthroplasty have been reported in patients with psychological, drug, alcohol, behavioral, and neurocognitive problems as well as fall risk and physical deconditioning 12, [33] [34] [35] . As a result, authors have suggested that tobacco cessation, diabetes management, weight loss, S. aureus decolonization measures, cognitive behavioral therapy, physical therapy, "pre-rehabilitation," drug and alcohol counseling, and other interventions may help to minimize modifiable risk factors for readmission. Given the abundant literature on readmission and the lack of clear guidelines regarding the optimization of the modifiable risk factors associated with readmission, it is difficult for the practicing surgeon to assess the risk of readmission, identify modifiable risk factors, and optimize those risk factors that may potentially lead to a readmission. This results from lack of a comprehensive risk assessment tool that quantifies the level of modifiable risk factors that are associated with improved outcomes. In light of this, we developed the RRAT, which is part of the POSH, or Perioperative Orthopaedic Surgical Home, model and allows for risk stratification and clinical treatment to mitigate modifiable risk factors in high-risk patients. The proposed future aims of this model after screening total joint arthroplasty patients for modifiable risk factors with the RRAT include (1) delaying total joint arthroplasty in patients with excessive modifiable risk factors, (2) decreasing the morbidity associated with total joint arthroplasty procedures and also reducing readmission, and (3) intervening to optimize modifiable risk factors before undertaking any surgical intervention when the risk of readmission is too high.
In our study, we evaluated the relationship between the RRAT score, as generated from the scoring tool based on potentially modifiable risk factors, and readmission after hip or knee arthroplasty. Based on our analysis of the estimated odds of being readmitted at each RRAT scoring level, higher RRAT scores are correlated with a greater chance of readmission and thus can be a clinically meaningful predictor of readmission. An RRAT score of ‡3 was found to be a reasonable point that should alert the surgeon, payer, patient, and hospital of a higher risk of readmission. When surgery is delayed for such high-risk patients and a comprehensive counseling session is undertaken, these patients may express renewed interest in modifying the risk factors. Models such as this can potentially be beneficial to the patient, provider, and payer. This process of identifying high-risk patients and informing them of the increased risk of total joint arthroplasty surgery can present a "teachable moment" and an opportunity for shared decision-making discussions.
When we analyzed the association of individual risk factors with readmission, some factors were not significant even though those risk factors have been demonstrated to be significant in other studies. This can be explained in two possible ways: (1) The study population was too small to evaluate these multiple factors simultaneously. (2) Even if a single effect is not significant, the item may still be meaningful for the RRAT because the relationship among items may not be linear as we assumed. We have shown synergistic effects of tobacco use and obesity in previous larger series dealing with infection risk after total joint arthroplasty 18 .
Although the results of this analysis show the potential utility of the RRAT in identifying and risk-stratifying patients who may be readmitted, it needs to be further evaluated and validated in larger cohorts. This would involve identifying the high-risk patients on the basis of the criteria used to develop the scoring tool, weighting and assigning an RRAT score for each based on the level of risk conferred by each factor, and then comparing their rates of readmission to those of a non-high-risk cohort using the same scoring algorithm.
There are several limitations to this study. Despite the methodology of choosing two control cohorts for non-readmitted patients, the drawbacks of a retrospective study remain. Another source of weakness is that the current data set may include patients who underwent treatment for their complications at a different center. These missing readmitted cases may have reduced the power of the study to demonstrate the significance of the scoring effect, which was an aim of this study, but would not have harmed the validity of our conclusion regarding the existence of the effect. However, as an accurate effect size still remains in question, a large prospective study in which all of the readmissions are captured in the same institution is necessary. Currently, because of the small sample size, we cannot definitively state (1) whether the selection of each item is relevant, (2) what the relative importance of each item is, and (3) how the items are related to each other. We believe that a larger cohort will allow us to provide the answer to those questions. In a subsequent study, we also need to further investigate how to address age issues.
In conclusion, population health management, cost-effective care, and optimization of outcomes to maximize value are the new maxims for health-care delivery in the twenty-first-century United States. In our study, we assessed a tool that quantifies modifiable risk factors for readmission after total joint arthroplasty and scores the overall risk in an easy manner. Identifying these patients and modifying the risk factors may ultimately reduce readmission rates, which renders it potentially clinically useful. n
